Abstract
It is a challenge to monitor patients with Crohn's disease who remain symptomatic despite anti-tumor necrosis factor therapy. Clinicians must use a systematic approach for each patient and obtain objective evidence about disease activity and response to therapy. Alternate etiologies for symptoms should be sought and treated, if found. Active Crohn's disease despite therapy requires reassessment and adjustments to management plans.
Original language | English (US) |
---|---|
Pages (from-to) | 395-399 |
Number of pages | 5 |
Journal | Clinical Gastroenterology and Hepatology |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - May 2011 |
Keywords
- Anti-TNF Therapy
- Crohn's Disease
- Treatment Failure
ASJC Scopus subject areas
- Hepatology
- Gastroenterology